| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 10.425 | 8.421 | 12.758 | 16.688 | 11.455 | 3.514 |
| Total Income - EUR | - | - | - | - | 10.425 | 8.421 | 12.962 | 16.934 | 11.718 | 4.089 |
| Total Expenses - EUR | - | - | - | - | 977 | 100 | 835 | 5.030 | 5.695 | 6.371 |
| Gross Profit/Loss - EUR | - | - | - | - | 9.448 | 8.320 | 12.126 | 11.904 | 6.022 | -2.281 |
| Net Profit/Loss - EUR | - | - | - | - | 9.136 | 8.175 | 11.893 | 11.489 | 5.105 | -2.281 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Brukenthal Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 3.087 | 13.163 | 7.862 | 2.586 |
| Current Assets | - | - | - | - | 9.867 | 12.620 | 12.805 | 4.877 | 14.677 | 17.582 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 3.035 | 186 | 1.891 | 2.942 | 2.329 | 2.316 |
| Cash | - | - | - | - | 6.832 | 12.434 | 10.914 | 1.935 | 5.698 | 8.653 |
| Shareholders Funds | - | - | - | - | 9.112 | 9.792 | 13.464 | 15.607 | 20.665 | 18.268 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 755 | 827 | 675 | 924 | 611 | 886 |
| Income in Advance | - | - | - | - | 0 | 2.001 | 1.753 | 1.513 | 1.264 | 1.013 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Brukenthal Med S.r.l.